Organon & Co. OGN recently announced findings from a pooled sub-analysis of its Phase 3 ADORING 1 and ADORING 2 pivotal trials assessing VTAMA (tapinarof) cream, 1%, in pediatric patients with

The Gap, Inc. GAP is expected to register top-line growth when it reports fourth-quarter fiscal 2025 results on March 5, after the closing bell. For revenues, the Zacks Consensus Estimate is pegged

Honeywell International Inc. HON is witnessing solid momentum in its commercial aviation aftermarket business, driven by solid demand in the air transport market and supply-chain improvements

Dycom Industries, Inc. DY is scheduled to report its fourth-quarter fiscal 2026 results on March 4, before the opening bell.In the last reported quarter, the company’s adjusted earnings and contract

Visa Inc. V has completed the acquisition of Prisma Medios de Pago S.A.U. and Newpay S.A.U. in Argentina, expanding its footprint in the country’s payments ecosystem. The move comes just weeks after

Berkshire Hathaway's BRK.B fourth-quarter 2025 operating earnings of $4.73 per share decreased 27.7% year over year and missed the Zacks Consensus Estimate by 8.9%.Operating earnings were $19.2

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to